BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12164865)

  • 21. Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.
    Bitzan M; Klemt M; Steffens R; Müller-Wiefel DE
    Infection; 1993; 21(3):140-5. PubMed ID: 8365810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology.
    Khan F; Proulx F; Lingwood CA
    Kidney Int; 2009 Jun; 75(11):1209-1216. PubMed ID: 19212418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro.
    Bitzan M; Richardson S; Huang C; Boyd B; Petric M; Karmali MA
    Infect Immun; 1994 Aug; 62(8):3337-47. PubMed ID: 8039905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour necrosis factor alpha is not an essential component of verotoxin 1-induced toxicity in mice.
    Wolski VM; Soltyk AM; Brunton JL
    Microb Pathog; 2002 Jun; 32(6):263-71. PubMed ID: 12137753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker.
    Heath-Engel HM; Lingwood CA
    Angiogenesis; 2003; 6(2):129-41. PubMed ID: 14739619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental verocytotoxemia in rabbits.
    Richardson SE; Rotman TA; Jay V; Smith CR; Becker LE; Petric M; Olivieri NF; Karmali MA
    Infect Immun; 1992 Oct; 60(10):4154-67. PubMed ID: 1398926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias.
    Arab S; Russel E; Chapman WB; Rosen B; Lingwood CA
    Oncol Res; 1997; 9(10):553-63. PubMed ID: 9507533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
    Waddell T; Head S; Petric M; Cohen A; Lingwood C
    Biochem Biophys Res Commun; 1988 Apr; 152(2):674-9. PubMed ID: 3284526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid.
    Ludwig K; Karmali MA; Smith CR; Petric M
    Can J Microbiol; 2002 Jan; 48(1):99-103. PubMed ID: 11888169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Globotriaosyl ceramide receptor function - where membrane structure and pathology intersect.
    Lingwood CA; Binnington B; Manis A; Branch DR
    FEBS Lett; 2010 May; 584(9):1879-86. PubMed ID: 19948172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Uses of Bacterial Subunit Toxins.
    Lingwood C
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verotoxin-binding in human renal sections.
    Lingwood CA
    Nephron; 1994; 66(1):21-8. PubMed ID: 8107950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and frequency of VT1, VT2 and eaeA genes in Escherichia coli O157 and O157:H7 strains isolated from cattle, cattle carcasses and abattoir environment in Istanbul.
    Yilmaz A; Gun H; Ugur M; Turan N; Yilmaz H
    Int J Food Microbiol; 2006 Feb; 106(2):213-7. PubMed ID: 16307816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA; Lingwood CA
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characteristics and molecular biology of verotoxin produced by enterohemorrhagic Escherichia coli].
    Iijima Y; Honda T
    Nihon Rinsho; 1997 Mar; 55(3):646-50. PubMed ID: 9086774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verotoxin Receptor-Based Pathology and Therapies.
    Lingwood C
    Front Cell Infect Microbiol; 2020; 10():123. PubMed ID: 32296648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a soluble pseudo-receptor on verotoxin 2-induced toxicity.
    Takenaga M; Igarashi R; Higaki M; Nakayama T; Yuki K; Mizushima Y
    J Infect Chemother; 2000 Mar; 6(1):21-5. PubMed ID: 11810526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary tubular impairment by verocytotoxin in hemolytic uremic syndrome].
    Uchida H; Fujimoto J; Takeda T
    Nihon Rinsho; 1997 Mar; 55(3):726-30. PubMed ID: 9086788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes.
    Mahfoud R; Manis A; Lingwood CA
    J Lipid Res; 2009 Sep; 50(9):1744-55. PubMed ID: 18716315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro.
    Shi PL; Binnington B; Sakac D; Katsman Y; Ramkumar S; Gariepy J; Kim M; Branch DR; Lingwood C
    Toxins (Basel); 2012 Dec; 4(12):1517-34. PubMed ID: 23242319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.